Skip to main content

Dr. Jonathan Fox

Equibles does not estimate personal net worth.

Get an email with a short summary when Edgewise Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get EWTX alerts

About Dr. Jonathan Fox

Dr. Jonathan Fox is recorded as Board Member at Edgewise Therapeutics, Inc. (EWTX) since March 2, 2023. Edgewise Therapeutics, Inc. reported in an 8-K filed March 6, 2023 that Dr. Jonathan Fox was appointed Class III director, effective March 2, 2023. Edgewise Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edgewise Therapeutics, Inc. includes Kevin Koch (CEO and Board Member), Michael P. Nofi (CFO), R. Michael Carruthers (CFO) and 5 others.

“On March 2, 2023, the Board of Directors (the "Board") of Edgewise Therapeutics, Inc. (the "Company") appointed Dr. Jonathan Fox to serve (i) as a Class III director, with a term expiring at the Company's 2024 annual meeting of stockholders, and (ii) as a member of the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee").”
Edgewise Therapeutics, Inc. Form 8-K, filed March 6, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Edgewise Therapeutics, Inc.

Recent activity